Astrazeneca plc
NASDAQ: AZN
$70.76
-$0.21 (-0.3%)
Closing Price on June 18, 2025
AZN Stock Chart and Intraday Price
AZN Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, GB |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 200,284.54M USD |
| Shares Outstanding | 3,100,380,000 |
AZN Articles
We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true. Over the past week, several companies reported strong earnings,...
Published:
Live Updates Live Coverage Has Ended Bear Market Territory for Small Caps 2:25 pm by Gerelyn Terzo Nearly $2 trillion in value disappeared from the S&P 500 today in response to the tariff...
Published:
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Published:
These four large-cap dividend stocks offer value, upside potential, and strong dividend coverage. They are top picks for the coming year.
Published:
Finding the “best” growth stocks to buy really is a subjective task, isn’t it? What’s considered to be the best for one investor isn’t necessarily the same for another. That’s because...
Published:
These five blue chip dividend stocks would be ideal for investors who had to hold them forever, as they provide reliable streams of passive income.
Published:
George Soros is among the most renowned and controversial hedge fund managers on the planet. Well known for his political affiliations, which are now opposite to a number of politically-charged CEOs...
Published:
Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making $1 billion on the deal. His currency speculation earned him the...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
24/7 Insights With the S&P 500 up 15% year-to-date, a correction could be coming in the third quarter. Stocks that pay dividends will be in big demand when interest rates start to fall over the...
Published:
24/7 Insights Quality dividend stocks outperform non-dividend stocks for shareholders. Dividend stocks can deliver dependable passive income streams. Access 2 legendary, high-yield dividend stocks...
Published:
With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Analysts have been cutting ratings and price targets recently, but here are four stocks that defying the downward pressure.
Published:
This year’s Artificial Intelligence rally led by the so-called “Magnificent 7” has been fantastic if you owned those stocks. The reality is the great bulk of the S&P 500 is treading water...
Published:
